Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Psychopharmacology

• Publication date

  2006-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/0269881106061514PMID 16574714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histamine-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue cultures.

  2005cited by this paper
• Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs

  2005cited by this paper
• Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture.

  2005cited by this paper
• Multiple molecular and neuropharmacological effects of MDMA (Ecstasy).

  2004cited by this paper
• Hyponatremia in Critically Ill Neurological Patients

  2003cited by this paper
• Serotonin Receptors Involved in Vasopressin and Oxytocin Secretion

  2003cited by this paper
• Review of deaths related to taking ecstasy, England and Wales, 1997-2000

  2003cited by this paper
• The effect of 3,4‐methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus

  2002cited by this paper
• Action of MDMA (Ecstasy) and Its Metabolites on Arginine Vasopressin Release

  2002cited by this paper
• Serotonergic involvement in stress-induced vasopressin and oxytocin secretion.

  2002cited by this paper
• Arginine vasopressin release in response to the administration of 3,4‐methylenedioxymethamphetamine (“ecstasy”): is metabolism a contributory factor?

  2001cited by this paper
• Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

  2001cited by this paper
• The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

  2001cited by this paper
• Three cases of fatal paramethoxyamphetamine overdose.

  2001cited by this paper
• Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA).

  2001cited by this paper
• Drug Information Systems, Early Warning, and New Drug Trends: Can Drug Monitoring Systems Become More Sensitive to Emerging Trends in Drug Consumption?

  2000cited by this paper
• Metabolic consequences of drug misuse.

  2000cited by this paper
• Hyponatraemia and seizures after ecstasy use

  1999cited by this paper
• Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.

  1999cited by this paper
• The effect of melatonin administration on pituitary hormone secretion in man

  1999cited by this paper
• Death rate from use of ecstasy or heroin.

  1999cited by this paper
• Ecstasy use in Australia: patterns of use and associated harm.

  1999cited by this paper
• Bright light exposure and pituitary hormone secretion

  1998cited by this paper
• MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

  1998influential reference
• Low-dose MDMA ("ecstasy") induces vasopressin secretion.

  1998cited by this paper
• Adverse effects of stimulant drugs in a community sample of drug users.

  1997cited by this paper
• Acute hyponatraemia.

  1997cited by this paper
• Myelinolysis after Correction of Hyponatremia

  1997cited by this paper
• Musical preference as an indicator of adolescent drug use.

  1997cited by this paper
• Hyponatraemia at a rave.

  1997cited by this paper
• Cerebral oedema after ingestion of MDMA (“ecstasy”) and unrestricted intake of water

  1996cited by this paper
• Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.

  1995cited by this paper
• Use of Drugs at ‘Raves’

  1995cited by this paper
• Hazards associated with the recreational drug 'ecstasy'.

  1994cited by this paper
• Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion.

  1994cited by this paper
• Hyponatraemia after ingestion of “ectasy”

  1994influential reference
• Pursuit of Ecstasy: The Mdma Experience

  1994cited by this paper
• Pursuit of Ecstasy: The MDMA Experience

  1994cited by this paper
• Syndrome of inappropriate secretion of antidiuretic hormone induced by diclofenac.

  1993cited by this paper
• Hyponatraemia and catatonic stupor after taking "ecstasy".

  1993influential reference
• Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

  1992cited by this paper
• Postoperative Hyponatremic Encephalopathy in Menstruant Women

  1992cited by this paper
• Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat.

  1991cited by this paper
• The management of hyponatremic emergencies.

  1991cited by this paper
• Plasma vasopressin and oxytocin in response to exercise and during a day-night cycle in man.

  1982cited by this paper
• Water intoxication and oxytocin.

  1982cited by this paper
• Rapid correction of severe hyponatremia with intravenous hypertonic saline solution.

  1982cited by this paper
• Effects of various ambient temperatures and of heating and cooling the hypothalamus and cervical spinal cord on antidiuretic hormone secretion and urinary osmolality in pigs.

  1976cited by this paper
• Textbook of Surgery

  1965cited by this paper

• Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model

  2025cites this paper
• Characterization of the Neurochemical and Behavioral Effects of the Phenethylamine 2-Cl-4,5-MDMA in Adolescent and Adult Male Rats

  2024cites this paper
• The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns

  2024cites this paper
• Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia

  2024cites this paper
• Une nouvelle prise en charge innovante dans le traitement des troubles de stress post-traumatique : la thérapie assistée par MDMA, approche historique et analyse des protocoles actuels

  2023cites this paper
• Enhancing Fear Extinction: Pharmacological Approaches.

  2023cites this paper
• MDMA for the treatment of misophonia, a proposal

  2022cites this paper
• 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) in adults

  2022cites this paper
• Couple Therapy With MDMA—Proposed Pathways of Action

  2021cites this paper
• Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field.

  2021cites this paper
• MDMA to Treat PTSD in Adults.

  2021cites this paper
• The gluco-regulatory effects of 3,4-Methylenedioxymethamphetamine (MDMA): A controlled n-of-2 self-experimentation

  2021cites this paper
• Kidney Disease and Electrolyte Disorders in the Context of Drug Use

  2020cites this paper
• MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t

  2020cites this paper
• Hyponatrémie du samedi soir : penser à l’ecstasy !

  2020cites this paper
• Hydration, Arginine Vasopressin, and Glucoregulatory Health in Humans: A Critical Perspective

  2019cites this paper
• Effects of MDMA on attention to positive social cues and pleasantness of affective touch

  2019cites this paper
• Augmentation of Extinction and Inhibitory Learning in Anxiety and Trauma-Related Disorders.

  2019cites this paper
• Novel Psychoactive Drugs

  2019cites this paper
• Opioids and the hormone oxytocin.

  2019cites this paper
• Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

  2018cites this paper
• Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder

  2018cites this paper
• SIADH and water intoxication related to ecstasy

  2018cites this paper
• MDMA assisted psychotherapy - a psychobiological analysis and critique.

  2018cites this paper
• The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish

  2017cites this paper
• Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2017cites this paper
• Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist’s Perspective

  2017cites this paper
• Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage

  2017cites this paper
• Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy

  2017cites this paper
• Decision‐making in chronic ecstasy users: a systematic review

  2017cites this paper
• From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders

  2016cites this paper
• The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?

  2016cites this paper
• Drug addiction: An affective-cognitive disorder in need of a cure.

  2016cites this paper
• Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’

  2016influential citation
• Adversity impacting on oxytocin and behaviour: timing matters

  2016cites this paper
• Clinical applications of hallucinogens: A review.

  2016cites this paper
• MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.

  2016cites this paper
• Exploring MDMA: From Neurotoxicity to Therapeutic Potential

  2016cites this paper
• Ecstasy (MDMA) and its effects on kidneys and their treatment: a review

  2016cites this paper
• Title : MDMA impairs response to water intake in healthy volunteers Author List :

  2015cites this paper
• Effects of psychostimulants on social interaction in adult male rats

  2015cites this paper
• 4-Fluoroamphetamine in the Netherlands: more than a one-night stand.

  2015cites this paper
• Effect of drugs of abuse on social behaviour: a review of animal models

  2015cites this paper
• Running Head : Perceived parental neglect in ecstasy-polydrug users

  2015cites this paper
• MDMA Impairs Response to Water Intake in Healthy Volunteers

  2015cites this paper
• Individual differences underlying susceptibility to addiction: Role for the endogenous oxytocin system.

  2014influential citation
• MDMA decreases the effects of simulated social rejection.

  2014cites this paper
• HYPONATREMIA IN PREDIALYSIS HOSPITALIZED PATIENTS: AN UPDATE ON CLINICAL DATA AND MANAGEMENT

  2014cites this paper
• Ecstasy, legal highs and designer drug use: A Canadian perspective

  2014cites this paper
• Effects of ecstasy on cooperative behaviour and perception of trustworthiness: A naturalistic study

  2014cites this paper
• Oxytocinergic regulation of endogenous as well as drug-induced mood.

  2014cites this paper
• Disorders of sodium and water balance.

  2014cites this paper
• Bachelor Degree Project in Cognitive Neuroscience 15 Ects Spring Term 2013 Neurobiological Rationale for Treating Post- Traumatic Stress Disorder with 3,4- Methylenedioxymethylamphetamine Methylenedioxymethamphetamine Running Head: Rationale for Treating Ptsd with Mdma 1 Treating Horror with Ecstasy

  2013influential citation
• A brief history of oxytocin and its role in modulating psychostimulant effects

  2013cites this paper
• Exploring the role of intra-nasal oxytocin on the partner preference effect in humans.

  2013cites this paper
• High incidence of mild hyponatraemia in females using ecstasy at a rave party.

  2013cites this paper
• Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

  2013cites this paper
• A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

  2013cites this paper
• Study of the toxicological interactions between amphetamine designer drugs in the context of polydrug abuse

  2013cites this paper
• Ecstacy-associated hyponatremia: why are women at risk?

  2013cites this paper
• The social brain: neurobiological basis of affiliative behaviours and psychological well-being.

  2013cites this paper
• Reply to ‘MDMA can increase cortical levels by 800% in dance clubbers’ Parrott et al.

  2013cites this paper
• MDMA can increase cortisol levels by 800% in dance clubbers

  2013cites this paper
• The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction

  2012cites this paper
• Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption

  2012influential citation
• Breaking the loop: oxytocin as a potential treatment for drug addiction.

  2012cites this paper
• Alcohol and drugs in epilepsy: Pathophysiology, presentation, possibilities, and prevention

  2012influential citation
• Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT

  2012influential citation
• Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users.

  2012cites this paper
• Monitoring illicit psychostimulants and related health issues

  2012cites this paper
• psychotherapy for treatment of resistant , chronic Post-Traumatic Stress Disorder ( PTSD ) A randomized , controlled pilot study of MDMA ( ± 3 , 4-Methylenedioxymethamphetamine )-assisted

  2012cites this paper
• assisted psychotherapy : a Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects

  2012cites this paper
• MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions

  2012cites this paper
• Are Females More Sensitive to MDMA-Related Discriminative Stimuli?

  2011cites this paper
• Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat

  2011cites this paper
• Prosocial effects of oxytocin and clinical evidence for its therapeutic potential.

  2011cites this paper
• MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.

  2011cites this paper
• Drugs and Pituitary Function

  2011cites this paper
• Evaluation of Renal Function, Water, Electrolytes, and Acid-Base Balance

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Monitoring illicit psychostimulants and related health issues

  2011cites this paper
• Evaluation of Enzyme Immunoassay and Radioimmunoassay Methods for the Measurement of Plasma Oxytocin

  2011cites this paper
• Is ecstasy an ‘empathogen’? Effects of MDMA on prosocial feelings and identification of emotional states in others

  2011cites this paper
• The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

  2011cites this paper
• MDMA: interactions with other psychoactive drugs.

  2011influential citation
• Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.

  2010cites this paper
• Neurotoxicidade da "Ectasy" e dos seus metabolitos em células humanas dopaminérgicas SH-SY5Y

  2010cites this paper
• Chapter 15. Disorders of Water Balance

  2010cites this paper
• Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination

  2010cites this paper
• The safety and efficacy of 3 , 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic , treatment-resistant posttraumatic stress disorder : the first randomized controlled pilot study

  2010cites this paper
• Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology

  2010cites this paper
• Smoking, alcohol, and recreational drug abuse

  2009cites this paper
• Effects of MDMA on sociability and neural response to social threat and social reward

  2009cites this paper
• Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

  2009cites this paper
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cites this paper
• CHAPTER 27 – Illicit Drugs I: Amphetamines

  2009cites this paper
• The effects of perceived parenting style on the propensity for illicit drug use: the importance of parental warmth and control.

  2008cites this paper
• Substance Abuse: Hallucinogen‐ and MDMA‐Related Disorders

  2008cites this paper
• The social psychology of gender: How power and intimacy shape gender relations.

  2008cites this paper
• From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use?

  2008cites this paper
• The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney.

  2008cites this paper